Terms: = Breast cancer AND CHEK2, bA444G7, 11200, ENSG00000183765, O96017, RAD53, RP11-436C9_1, PP1425, LFS2, CHK2, HuCds1 AND Prognosis
11753 results:
1. The interrelationship between obesity and race in breast cancer prognosis: a prospective cohort study.
Schindler EA; Takita C; Collado-Mesa F; Reis IM; Zhao W; Yang GR; Acosta LG; Hu JJ
BMC Womens Health; 2024 May; 24(1):312. PubMed ID: 38816709
[TBL] [Abstract] [Full Text] [Related]
2. Risk of second primary thyroid cancer in cancer survivors.
Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
[TBL] [Abstract] [Full Text] [Related]
3. Genomic characterization reveals distinct mutational landscapes and therapeutic implications between different molecular subtypes of triple-negative breast cancer.
Li RQ; Yan L; Zhang L; Ma HX; Wang HW; Bu P; Xi YF; Lian J
Sci Rep; 2024 May; 14(1):12386. PubMed ID: 38811720
[TBL] [Abstract] [Full Text] [Related]
4. EpCAM-CD24+ circulating cells associated with poor prognosis in breast cancer patients.
Perelmuter VM; Grigoryeva ES; Savelieva OE; Alifanov VV; Andruhova ES; Zavyalova MV; Bragina OD; Garbukov EY; Menyailo ME; Khozyainova AA; Denisov EV; Cherdyntseva NV; Tashireva LA
Sci Rep; 2024 May; 14(1):12245. PubMed ID: 38806508
[TBL] [Abstract] [Full Text] [Related]
5. Hypoxia-inducible factor in breast cancer: role and target for breast cancer treatment.
Zhi S; Chen C; Huang H; Zhang Z; Zeng F; Zhang S
Front Immunol; 2024; 15():1370800. PubMed ID: 38799423
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic potential of lipid profiling in cancer patients: a systematic review of mass spectrometry-based studies.
Takanashi Y; Kahyo T; Sekihara K; Kawase A; Setou M; Funai K
Lipids Health Dis; 2024 May; 23(1):154. PubMed ID: 38796445
[TBL] [Abstract] [Full Text] [Related]
7. The Association between Mutational Signatures and Clinical Outcomes among Patients with Early-Onset breast cancer.
Basmadjian RB; O'Sullivan DE; Quan ML; Lupichuk S; Xu Y; Cheung WY; Brenner DR
Genes (Basel); 2024 May; 15(5):. PubMed ID: 38790221
[TBL] [Abstract] [Full Text] [Related]
8. BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.
Aglan SA; Awad AM; Elwany YN; Shawky S; Salam RMA; Omar RS; Ghazala RAM; Soliman NA; Khedr MI; Kandil LS; Sultan M; Hamed Y; Kandil NS
Mol Genet Genomics; 2024 May; 299(1):56. PubMed ID: 38787424
[TBL] [Abstract] [Full Text] [Related]
9. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
He ZX; Li J; Wang QF; Cheng Q; Ni SJ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
[No Abstract] [Full Text] [Related]
10. [The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma].
Li DP; Zhang JM; Zhang YH; Hu LF; Gao Y; Wei SF; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1825-1830. PubMed ID: 38782750
[No Abstract] [Full Text] [Related]
11. Lactylproteome analysis indicates histone H4K12 lactylation as a novel biomarker in triple-negative breast cancer.
Cui Z; Li Y; Lin Y; Zheng C; Luo L; Hu D; Chen Y; Xiao Z; Sun Y
Front Endocrinol (Lausanne); 2024; 15():1328679. PubMed ID: 38779451
[TBL] [Abstract] [Full Text] [Related]
12. Prophylactic central lymph node dissection in cN0 papillary thyroid cancer: a comparative study of via breast and transoral approach versus via breast approach alone.
Qiu R; Fu J
Front Endocrinol (Lausanne); 2024; 15():1356739. PubMed ID: 38774230
[TBL] [Abstract] [Full Text] [Related]
13. Prevention of persistent pain with lidocaine infusions in breast cancer surgery (PLAN): study protocol for a multicenter randomized controlled trial.
Khan JS; Gilron I; Devereaux PJ; Clarke H; Ayach N; Tomlinson G; Quan ML; Ladha KS; Choi S; Munro A; Brull R; Lim DW; Avramescu S; Richebé P; Hodgson N; Paul J; McIsaac DI; Derzi S; Zbitnew GL; Easson AM; Siddiqui NT; Miles SJ; Karkouti K;
Trials; 2024 May; 25(1):337. PubMed ID: 38773653
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer.
Hao Y; Zhang X; Cui G; Qi X; Jiang Z; Yu L
Cancer Med; 2024 May; 13(10):e7296. PubMed ID: 38770671
[TBL] [Abstract] [Full Text] [Related]
15. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
Qi G; Zhang X; Gai X; Yan X
PeerJ; 2024; 12():e17377. PubMed ID: 38766488
[TBL] [Abstract] [Full Text] [Related]
16. A meta-analysis of randomized controlled trials comparing breast-conserving surgery and mastectomy in terms of patient survival rate and quality of life in breast cancer.
Li S; Li X; Li D; Zhao Q; Zhu L; Wu T
Int J Qual Health Care; 2024 May; 36(2):. PubMed ID: 38753325
[TBL] [Abstract] [Full Text] [Related]
17. CircAGFG1 Promotes Ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
[TBL] [Abstract] [Full Text] [Related]
18. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary.
Tang L; Zhu Y; Du Y; Long X; Long Y; Tang Y; Liu J
J Cancer Res Clin Oncol; 2024 May; 150(5):256. PubMed ID: 38750402
[TBL] [Abstract] [Full Text] [Related]
20. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
[TBL] [Abstract] [Full Text] [Related]
[Next]
